Company Information

Company Profile

VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen's three drug candidates, PH94B, PH10, and AV-101, has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets.

Contact Information

Investor Relations
Mark A. McPartland
Vice President, Corporate Development and Investor Relations
T: (650) 577-3606
markmcp@vistagen.com

Company Info

Address:
343 Allerton Avenue
South San Francisco, CA 94080

Telephone:
(650) 577-3600

Fax:
(888) 482-2602

Industry Classifications

Sector:
Healthcare

Industry:
Pharmaceuticals

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)